Version 1
: Received: 11 July 2024 / Approved: 12 July 2024 / Online: 15 July 2024 (10:48:08 CEST)
How to cite:
Islam, N.; Galijatović, A.; Kozarić, S.; Hrapović, A.; Tipura, A.; Kovalenko, B.; Hajdarpašić, M.; Bourghli, A. A.; Lokvančić, H.; Sezer, A.; Aljabali, A. A.; Tambuwala, M. M.; Hromić-Jahjefendić, A.; Uversky, V. N. Biomaterials in Drug Delivery and Clinical Applications. Preprints2024, 2024071028. https://doi.org/10.20944/preprints202407.1028.v1
Islam, N.; Galijatović, A.; Kozarić, S.; Hrapović, A.; Tipura, A.; Kovalenko, B.; Hajdarpašić, M.; Bourghli, A. A.; Lokvančić, H.; Sezer, A.; Aljabali, A. A.; Tambuwala, M. M.; Hromić-Jahjefendić, A.; Uversky, V. N. Biomaterials in Drug Delivery and Clinical Applications. Preprints 2024, 2024071028. https://doi.org/10.20944/preprints202407.1028.v1
Islam, N.; Galijatović, A.; Kozarić, S.; Hrapović, A.; Tipura, A.; Kovalenko, B.; Hajdarpašić, M.; Bourghli, A. A.; Lokvančić, H.; Sezer, A.; Aljabali, A. A.; Tambuwala, M. M.; Hromić-Jahjefendić, A.; Uversky, V. N. Biomaterials in Drug Delivery and Clinical Applications. Preprints2024, 2024071028. https://doi.org/10.20944/preprints202407.1028.v1
APA Style
Islam, N., Galijatović, A., Kozarić, S., Hrapović, A., Tipura, A., Kovalenko, B., Hajdarpašić, M., Bourghli, A. A., Lokvančić, H., Sezer, A., Aljabali, A. A., Tambuwala, M. M., Hromić-Jahjefendić, A., & Uversky, V. N. (2024). Biomaterials in Drug Delivery and Clinical Applications. Preprints. https://doi.org/10.20944/preprints202407.1028.v1
Chicago/Turabian Style
Islam, N., Altijana Hromić-Jahjefendić and Vladimir N. Uversky. 2024 "Biomaterials in Drug Delivery and Clinical Applications" Preprints. https://doi.org/10.20944/preprints202407.1028.v1
Abstract
As the world population grows, fulfilling the need for biomaterials in the healthcare system becomes increasingly important. Biomaterials, which include metals, polymers, ceramics, and composites, play an important role in the creation of medical devices that improve people's lives. The European Society for Biomaterials described biomaterials as non-biological materials used in medical devices to interact with biological systems. This definition has developed to encompass materials that treat, assess, or replace tissues or bodily functions. Biocompatibility, as defined by the FDA, is a key feature of biomaterials, as is the requirement to fulfil design requirements such as mechanical performance, geometry, and electrical control. Over the last decade, advances in regenerative medicine and tissue engineering have boosted biomaterials' usage in medical applications dramatically. Despite its promise, scientists, engineers, and physicians continue to face significant challenges due to the complexity of biomaterials. Biomaterials have various benefits, including biodegradability, non-toxicity, and biocompatibility, making them extremely useful for replacing, sustaining, or improving biological activities in damaged tissues. They are used in a wide range of applications, including tissue engineering implants, human tissue healing and regeneration, medication delivery systems, and biosensors. This study gives insights into the fundamental characteristics, case studies, and ethical issues associated with the usage and use of biomaterials, further examining their potential and significance in healthcare and medicine.
Keywords
biomaterials; drug delivery; clinical applications; ethics
Subject
Biology and Life Sciences, Biology and Biotechnology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
,
,
